Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...

A recent study by the Greater Boston Food Bank and Mass General Brigham found that food insecurity continued to rise across ...

The new joint clinical practice guidelines from two endocrine societies make conditional recommendations for preconception, ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Somerville, Mass.-based Mass General Brigham and Amazon One Medical continue to expand their collaboration. The two organizations plan to open an Amazon One Medical primary care office in Wellesley, ...

In a significant move, the U.S. Food and Drug Administration granted approval for Kerendia for patients with heart failure ...

Q: How would you summarize your study for a lay audience?Our study examines how RNA in extracellular vesicles (EVs) can provide insights into ...

The US Food and Drug Administration has approved the use of finerenone (Kerendia) in heart failure (HF) patients with mildly ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.